Dr. Rodney E. Infante, MD, PhD

Dr. Infante practices at Parkland Memorial Hospital in Dallas, Texas, part of Parkland Health.

Dr. Infante's NPI, 1477817849, was assigned on June 29, 2012. Dr. Infante graduated from University of Texas Southwestern Medical School at Dallas in 2012. Dr. Infante holds Texas license R2884.

Dr. Infante's primary practice is Parkland Memorial Hospital, at 5200 Harry Hines Blvd, Dallas, TX 75235 in Dallas County. The practice phone is (214) 590-8000.

Dr. Infante's primary practice is Parkland Memorial Hospital in Dallas, Texas, part of Parkland Health. Dr. Infante is also affiliated with Texas Health Dallas. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Infante to 1 more clinical lab and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Infante practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Infante's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Infante's licenses on file in 2 states: Texas and Massachusetts.

CMS data shows 37 Medicare services from Dr. Infante across 2 procedure codes in 2024, for 64 Medicare patients. Medicare paid $3,653 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 64 Medicare patients who saw Dr. Infante in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Infante's median patient age at 60, with 51% women.

In 2019, Dr. Infante wrote 24 Medicare Part D claims. They cover 1 drug, with $364 in total drug cost. In 2016, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Infante for performance year 2024, reported as part of a group. Dr. Infante accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Infante, more than 42% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Infante, published from 2017 to 2025. 2022 was the busiest year, with 4. The most frequent topics are Cachexia, Cell Membrane and Cholesterol. Dr. Infante has published most often in Am J Clin Oncol. Dr. Infante's most frequent co-authors are Puneeth Iyengar, MD, PhD, Bhavani Sankar Gannavarapu, MD and Ernesto Manuel Llano, MD.

CMS Open Payments shows 15 general payments to Dr. Infante from 5 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 74% of the total. Pfizer Inc. paid the most, $22,830.

Dr. Infante graduated from University of Texas Southwestern Medical School at Dallas in 2012.